Trial intelligence / Profile preview

Zoledronic acid for chronic low back pain with Modic changes

2008-005351-14Phase 2Completed

Sponsor
University of Oulu
Start
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of zoledronic acid in lumbodynia (LBP) and Modic changes (MC), sponsored by University of Oulu. Primary endpoint: Change in low back pain intensity at one year. Started Sep 2008; status: completed.

02

Drugs

zoledronic acid
03

Conditions

lumbodynia (LBP)Modic changes (MC)

Beyond the preview

Go deeper on 2008-005351-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005351-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call